Medline Inc. (MDLN)
Medline Inc. (MDLN) from its SEC filings: 2025 revenue $28.4 billion (+12% vs the year before), net margin 4069%, free cash flow $1.3 billion. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Revenue (2025) | $28.4 billion |
| Revenue growth | +12% |
| Net income | $1.2 trillion |
| Net margin | 4069.4% |
| Free cash flow | $1.3 billion |
| Diluted EPS | $-0.01 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +12% |
| Cash | $2.3 billion |
| Long-term debt | $12.5 billion |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.